Alkylquinoline and alkylquinazoline kinase modulators

Details for Australian Patent Application No. 2006257945 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Baumann, Christian Andrew; Baindur, Nand; Kreutter, Kevin Douglas; Kim, Alexander J.; Xu, Guozhang; Tuman, Robert W.; Gaul, Michael David; Johnson, Dana L.

Agent Shelston IP

Pub. Number AU-A-2006257945

PCT Pub. Number WO2006/135721

Priority 60/730,919 27.10.05 US; 60/689,384 10.06.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135721 Priority application(s): WO2006/135721

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257947-Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acet yl]-pyrrolidine-2(S)-carbonitrile formulation

2006257940-Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells